Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (18)

2023

  1. The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma

    Nature Communications, Vol. 14, Núm. 1

2019

  1. Prediction of cancer risk based on study of genetic variants in healthy women in the Spanish population

    Revista de Senologia y Patologia Mamaria, Vol. 32, Núm. 3, pp. 94-99

2018

  1. Prognostic and predictive biomarkers for somatostatin analogs, peptide receptor radionuclide therapy and serotonin pathway targets in neuroendocrine tumours

    Cancer Treatment Reviews, Vol. 70, pp. 209-222

2016

  1. MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression

    Oncotarget, Vol. 7, Núm. 15, pp. 20068-20079

  2. Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers

    Nature Communications, Vol. 7

2014

  1. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells

    Stem Cells, Vol. 32, Núm. 5, pp. 1136-1148

  2. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia

    Nature Communications, Vol. 5

  3. Molecular classification of non-muscle-invasive bladder cancer (pTa Low-Grade, pT1 Low-Grade, and pT1 High-Grade Subgroups) using methylation of tumor-suppressor genes

    Journal of Molecular Diagnostics, Vol. 16, Núm. 5, pp. 564-572

2013

  1. A Quantitative Proteomic Analysis Uncovers the Relevance of CUL3 in Bladder Cancer Aggressiveness

    PLoS ONE, Vol. 8, Núm. 1

  2. DNA methylation signatures identify biologically distinct thyroid cancer subtypes

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 7, pp. 2811-2821

  3. Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: A 2-center prospective study

    Journal of Urology, Vol. 190, Núm. 2, pp. 723-730

  4. Polyamine-modulated factor-1 methylation predicts bacillus Calmette-Guérin response in patients with high-grade non-muscle-invasive bladder carcinoma

    European Urology, Vol. 63, Núm. 2, pp. 364-370

2012

  1. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma

    Clinical Cancer Research, Vol. 18, Núm. 10, pp. 2828-2837

2011

  1. Multiplexed methylation profiles of tumor suppressor genes in bladder cancer

    Journal of Molecular Diagnostics, Vol. 13, Núm. 1, pp. 29-40

2010

  1. Myopodin methylation is associated with clinical outcome in patients with T1G3 bladder cancer

    Journal of Urology, Vol. 184, Núm. 4, pp. 1507-1513

  2. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma

    The Lancet Oncology, Vol. 11, Núm. 4, pp. 366-372

2009

  1. Clinical predictors for germline mutations in Head and neck paraganglioma patients: cost reduction strategy in Genetic diagnostic process as fail-out

    Cancer Research, Vol. 69, Núm. 8, pp. 3650-3656

2004

  1. Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice

    Molecular and Cellular Biology, Vol. 24, Núm. 12, pp. 5304-5313